Adding an intensive lifestyle intervention to usual care slightly improves glycemic control but substantially reduces the need for glucose-lowering medication among patients with non–insulin-dependent type 2 diabetes, suggest trial results published as a preliminary communication in JAMA.

Twelve years of follow-up data from the EPIC study support the assertion that obesity is a cardiovascular risk factor in its own right, even in the absence of metabolic abnormalities.

A composite algorithm including the calprotectin biomarker can help physicians decide whether a diabetic foot ulcer needs antibiotic therapy, say researchers.

Results of a phase Ib trial published in Science Translational Medicine suggest that immunotherapy with proinsulin peptide is well tolerated in patients with newly diagnosed type 1 diabetes.

An online game delivering diabetes self-management education helps improve glycemic control in patients with type 2 diabetes, study results suggest.

Genetic variants associated with childhood body mass index correlate with the risk for type 1 diabetes, suggests an analysis of genome-wide association studies.